Cargando…

Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer

BACKGROUND: Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jinsoo, Jung, Bongsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dental Society of Anesthsiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995673/
https://www.ncbi.nlm.nih.gov/pubmed/35449784
http://dx.doi.org/10.17245/jdapm.2022.22.2.129
_version_ 1784684336502538240
author Park, Jinsoo
Jung, Bongsu
author_facet Park, Jinsoo
Jung, Bongsu
author_sort Park, Jinsoo
collection PubMed
description BACKGROUND: Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. METHODS: We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. RESULTS: The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. CONCLUSION: PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump.
format Online
Article
Text
id pubmed-8995673
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Dental Society of Anesthsiology
record_format MEDLINE/PubMed
spelling pubmed-89956732022-04-20 Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer Park, Jinsoo Jung, Bongsu J Dent Anesth Pain Med Original Article BACKGROUND: Patient-controlled analgesia (PCA) has been widely used as an effective medical treatment for pain and for postoperative analgesia. However, improper dose errors in intravenous (IV) administration of narcotic analgesics from a PCA infusion pump can cause patient harm. Furthermore, opioid overdose is considered one of the highest risk factors for patients receiving pain medications. Therefore, accurate delivery of opioid analgesics is a critical function of PCA infusion pumps. METHODS: We designed a microbalance method that consisted of a closed acrylic chamber containing a layer and an oil layer with an electronic balance. A commercially available infusion analyzer (IDA-5, Fluke Co., Everett, WA, USA) was used to measure the accuracy of the infusion flow rate from a commercially available smart PCA infusion pump (PS-1000, UNIMEDICS, Co., Ltd., Seoul, Korea) and compared with the results of the microbalance method. We evaluated the uncertainty of the flow rate measurement using the ISO guide (GUM:1995 part3). The battery life, delay time of the occlusion alarm, and bolus function of the PCA pump were also tested. RESULTS: The microbalance method was good in the short-term 2 h measurement, and IDA-5 was good in the long-term 24 h measurement. The two measurement systems can complement each other in the case of the measurement time. Regarding battery performance, PS-1000 lasted approximately 5 days in a 1 ml/hr flow rate condition without recharging the battery. The occlusion pressure alarm delays of PS-1000 satisfied the conventional alarm threshold of occlusion pressure (300-800 mmHg). Average accuracy bolus volume was measured as 63%, 95%, and 98.5% with 0.1 ml, 1 ml, and 2 ml bolus volume presets, respectively. A 1 ml/hr flow rate measurement was evaluated as 2.08% of expanded uncertainty, with a 95% confidence level. CONCLUSION: PS-1000 showed a flow accuracy to be within the infusion pump standard, which is ± 5% of flow accuracy. Occlusion alarm of PS-1000 was quickly transmitted, resulting in better safety for patients receiving IV infusion of opioids. PS-1000 is sufficient for a portable smart PCA infusion pump. The Korean Dental Society of Anesthsiology 2022-04 2022-03-25 /pmc/articles/PMC8995673/ /pubmed/35449784 http://dx.doi.org/10.17245/jdapm.2022.22.2.129 Text en Copyright © 2022 Journal of Dental Anesthesia and Pain Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Jinsoo
Jung, Bongsu
Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title_full Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title_fullStr Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title_full_unstemmed Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title_short Performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
title_sort performance evaluation study of a commercially available smart patient-controlled analgesia pump with the microbalance method and an infusion analyzer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995673/
https://www.ncbi.nlm.nih.gov/pubmed/35449784
http://dx.doi.org/10.17245/jdapm.2022.22.2.129
work_keys_str_mv AT parkjinsoo performanceevaluationstudyofacommerciallyavailablesmartpatientcontrolledanalgesiapumpwiththemicrobalancemethodandaninfusionanalyzer
AT jungbongsu performanceevaluationstudyofacommerciallyavailablesmartpatientcontrolledanalgesiapumpwiththemicrobalancemethodandaninfusionanalyzer